Cargando…
A Case for Abandoning Inpatient Fecal Occult Blood Testing
Fecal occult blood testing (FOBT) is currently Food and Drug Administration (FDA) approved only for colorectal cancer (CRC) screening. There is now widespread off-label use of FOBT in the hospital setting as a diagnostic test. Here we present a brief case and a more detailed review of the literature...
Autores principales: | Brennan, Gregory T, Parsons, Andrew S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381841/ https://www.ncbi.nlm.nih.gov/pubmed/32724753 http://dx.doi.org/10.7759/cureus.8807 |
Ejemplares similares
-
Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults
por: Alhuzaim, Waleed M, et al.
Publicado: (2023) -
Comparison of Findings From Fecal Occult Blood Test and Esophagogastroduodenoscopy With Histopathology Among Symptomatic Saudi Adults: A Retrospective Study
por: Alhuzaim, Waleed, et al.
Publicado: (2022) -
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
Fecal Occult Blood Test and Gastrointestinal Parasitic Infection
por: Wakid, Majed H.
Publicado: (2010) -
Advances in Fecal Occult Blood Tests: The FIT Revolution
por: Young, Graeme P., et al.
Publicado: (2014)